Delivery Order SPE2DB22D3301-SPE2DB25FY2BB

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.64 Firm Fixed Price Delivery Order is for the supply of SIMBRINZA 1%-0.2% eye drops, 8 ml, and has an ultimate completion date of June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,123.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with an ultimate completion date of January 23, 2025. The contract is a delivery order with a firm fixed price, and it is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,275.50 firm fixed-price delivery order is for the supply of Simbrinza 1%-0.2% eye drops (8 mL) and has an ultimate completion date of November 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the provision of SIMBRINZA 1%-0.2% eye drops, a pharmaceutical product, with a ceiling value of $1,554.17 and a period of performance ending on March 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,798.88 contract is for the provision of SIMBRINZA 1%-0.2% eye drops in 8 ml bottles, with a period of performance through March 12, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DX15D3201|SPE2DX24F3H9Q, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,252.77 firm fixed-price delivery order is for the supply of 4565778913 SIMBRINZA 1%-0.2% eye drops (8 mL) to support military treatment facilities and federal healthcare programs. The contract has no set-aside designation and will be completed by September 13, 2024. Amerisourcebergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Simbrinza 1%-0.2% eye drops in 8mL vials. The firm-fixed-price contract has a ceiling value of $10,804.98 and runs through August 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999, which provides a wide range of pharmaceutical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SIMBRINZA 1%-0.2% eye drops in 8 ml containers. The award, valued at $1,008.68, is a firm fixed-price contract with an ultimate completion date of August 30, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,759.58 firm fixed price contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a completion date of April 26, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Simbrinza 1%-0.2% eye drops, a branded medication, with a ceiling value of $3,413.73 and a completion date of March 21, 2024. The contract is a delivery order, with a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2BB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,397.24 Firm Fixed Price delivery order contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a period of performance through March 2025.

The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 6/21/25, 9:53 AM